OS was highly significant (p0.0001): 83% 5-year OS for women with breast cancer (median survival 129 months) versus 74% for men (median survival 101 months).
1
—
—
OS was highly significant (p0.0001): 83% 5-year OS for women with breast cancer (median survival 129 months) versus 74% for men (median survival 101 months).